This DNA Testing market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The DNA testing market size has grown rapidly in recent years. It will grow from $17.9 billion in 2024 to $20.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to the increasing incidence of chronic diseases, rising demand for precision medicine, rising direct-to-consumer (DTC) testing, rising demand for population genomics, growing forensic investigations, and demand for genetic screening.
The DNA testing market size is expected to see rapid growth in the next few years. It will grow to $31.38 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising incidences of genetic diseases, growing use of DNA diagnostics, growing healthcare infrastructure, growing awareness of disease prevention, rising investment by manufacturers, and increased adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in assisted reproductive technologies (art), miniaturization of testing devices, new DNA testing products, and development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).
The rising incidence of genetic disorders is anticipated to drive the growth of the DNA testing market in the foreseeable future. Genetic disorders result from abnormalities in an individual's DNA, leading to physical or developmental anomalies. Factors contributing to the increasing prevalence of genetic disorders include heightened awareness, advancements in diagnostic techniques, expanded genetic screening, and a growing prevalence of consanguineous marriages in certain populations. DNA testing plays an increasingly vital role in diagnosing, prognosticating, and making treatment decisions for individuals with genetic disorders, facilitating personalized medical interventions and family planning strategies based on an individual's genetic profile. For example, as per the World Health Organization (WHO) in February 2023, congenital diseases account for an estimated 240,000 infant deaths worldwide within 28 days of birth annually. Additionally, according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome in the United States each year, equating to around 1 in every 700 births. Thus, the escalating prevalence of genetic disorders is propelling the DNA testing market forward.
Key players in the DNA testing market are concentrating on developing advanced testing solutions such as precancer detection DNA tests to enhance early cancer diagnosis and treatment. Precancer detection DNA tests are diagnostic assays designed to detect genetic alterations or biomarkers associated with the early stages of cancer development. For instance, in November 2023, Lucid Diagnostics Inc., a US-based company specializing in esophageal cancer prevention diagnostics, introduced EsoGuard 2.0, the next-generation EsoGuard Esophageal DNA Test. This advanced DNA test employs molecular techniques and enhanced sample DNA yields to improve assay performance and reduce costs. The test involves collecting esophageal cell DNA using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to identify methylation at specific gene sites linked to esophageal precancer and cancer. Providing results indicating the presence or absence of epigenetic changes consistent with esophageal precancer and cancer, this DNA test is pivotal in cancer prevention and early detection efforts.
In June 2022, Zoetis Inc., a US-based company specializing in animal health products, acquired Basepaws for an undisclosed amount. This acquisition enables Zoetis to enhance its precision animal health portfolio by incorporating Basepaws' genetic testing services, which offer valuable insights into pet health and disease predispositions. Basepaws boasts one of the largest feline genomic and oral microbiome databases in the world, which will bolster Zoetis' research and development efforts and contribute to future advancements in pet care products. Basepaws is a US-based company known for its DNA testing services for cats.
Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics.
North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the DNA testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
DNA testing involves analyzing an individual's DNA, which contains the instructions for an organism's development, functioning, and traits. This process includes extracting DNA from cells, often obtained from bodily fluids or tissues such as blood, saliva, or hair, and then examining specific regions or sequences of the DNA molecule.
The primary product types in DNA testing include equipment, consumables, software, and services. Equipment comprises various instruments, devices, and tools utilized in the analysis of DNA samples. Various technologies are employed in DNA testing, including polymerase chain reaction (PCR)-based methods, in-situ hybridization, microarray analysis, and next-generation sequencing (NGS) for DNA diagnosis. These techniques find applications across various fields such as newborn DNA screening, prenatal DNA carrier screening, oncology diagnostics, histopathology, pre-implantation diagnosis, infectious disease diagnostics, pharmacogenomics diagnostic testing, identity verification, forensics, and more.
The DNA testing market research report is one of a series of new reports that provides DNA testing market statistics, including DNA testing industry global market size, regional shares, competitors with a DNA testing market share, detailed DNA testing market segments, market trends and opportunities, and any further data you may need to thrive in the DNA testing industry. This DNA testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The DNA testing market consists of revenues earned by entities by providing services such as paternity testing, maternity testing, genetic health risk assessment, carrier screening, pharmacogenomics testing, forensic DNA analysis, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA testing market also includes sales of sterile swabs, DNA collection kits, thermal cyclers, DNA sequencers, microarray platforms, DNA extraction kits, polymerase chain reaction (PCR) reagents, and microscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The DNA testing market size has grown rapidly in recent years. It will grow from $17.9 billion in 2024 to $20.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to the increasing incidence of chronic diseases, rising demand for precision medicine, rising direct-to-consumer (DTC) testing, rising demand for population genomics, growing forensic investigations, and demand for genetic screening.
The DNA testing market size is expected to see rapid growth in the next few years. It will grow to $31.38 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising incidences of genetic diseases, growing use of DNA diagnostics, growing healthcare infrastructure, growing awareness of disease prevention, rising investment by manufacturers, and increased adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in assisted reproductive technologies (art), miniaturization of testing devices, new DNA testing products, and development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).
The rising incidence of genetic disorders is anticipated to drive the growth of the DNA testing market in the foreseeable future. Genetic disorders result from abnormalities in an individual's DNA, leading to physical or developmental anomalies. Factors contributing to the increasing prevalence of genetic disorders include heightened awareness, advancements in diagnostic techniques, expanded genetic screening, and a growing prevalence of consanguineous marriages in certain populations. DNA testing plays an increasingly vital role in diagnosing, prognosticating, and making treatment decisions for individuals with genetic disorders, facilitating personalized medical interventions and family planning strategies based on an individual's genetic profile. For example, as per the World Health Organization (WHO) in February 2023, congenital diseases account for an estimated 240,000 infant deaths worldwide within 28 days of birth annually. Additionally, according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome in the United States each year, equating to around 1 in every 700 births. Thus, the escalating prevalence of genetic disorders is propelling the DNA testing market forward.
Key players in the DNA testing market are concentrating on developing advanced testing solutions such as precancer detection DNA tests to enhance early cancer diagnosis and treatment. Precancer detection DNA tests are diagnostic assays designed to detect genetic alterations or biomarkers associated with the early stages of cancer development. For instance, in November 2023, Lucid Diagnostics Inc., a US-based company specializing in esophageal cancer prevention diagnostics, introduced EsoGuard 2.0, the next-generation EsoGuard Esophageal DNA Test. This advanced DNA test employs molecular techniques and enhanced sample DNA yields to improve assay performance and reduce costs. The test involves collecting esophageal cell DNA using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to identify methylation at specific gene sites linked to esophageal precancer and cancer. Providing results indicating the presence or absence of epigenetic changes consistent with esophageal precancer and cancer, this DNA test is pivotal in cancer prevention and early detection efforts.
In June 2022, Zoetis Inc., a US-based company specializing in animal health products, acquired Basepaws for an undisclosed amount. This acquisition enables Zoetis to enhance its precision animal health portfolio by incorporating Basepaws' genetic testing services, which offer valuable insights into pet health and disease predispositions. Basepaws boasts one of the largest feline genomic and oral microbiome databases in the world, which will bolster Zoetis' research and development efforts and contribute to future advancements in pet care products. Basepaws is a US-based company known for its DNA testing services for cats.
Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics.
North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the DNA testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
DNA testing involves analyzing an individual's DNA, which contains the instructions for an organism's development, functioning, and traits. This process includes extracting DNA from cells, often obtained from bodily fluids or tissues such as blood, saliva, or hair, and then examining specific regions or sequences of the DNA molecule.
The primary product types in DNA testing include equipment, consumables, software, and services. Equipment comprises various instruments, devices, and tools utilized in the analysis of DNA samples. Various technologies are employed in DNA testing, including polymerase chain reaction (PCR)-based methods, in-situ hybridization, microarray analysis, and next-generation sequencing (NGS) for DNA diagnosis. These techniques find applications across various fields such as newborn DNA screening, prenatal DNA carrier screening, oncology diagnostics, histopathology, pre-implantation diagnosis, infectious disease diagnostics, pharmacogenomics diagnostic testing, identity verification, forensics, and more.
The DNA testing market research report is one of a series of new reports that provides DNA testing market statistics, including DNA testing industry global market size, regional shares, competitors with a DNA testing market share, detailed DNA testing market segments, market trends and opportunities, and any further data you may need to thrive in the DNA testing industry. This DNA testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The DNA testing market consists of revenues earned by entities by providing services such as paternity testing, maternity testing, genetic health risk assessment, carrier screening, pharmacogenomics testing, forensic DNA analysis, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA testing market also includes sales of sterile swabs, DNA collection kits, thermal cyclers, DNA sequencers, microarray platforms, DNA extraction kits, polymerase chain reaction (PCR) reagents, and microscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. DNA Testing Market Characteristics3. DNA Testing Market Trends and Strategies4. DNA Testing Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global DNA Testing Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the DNA Testing Market34. Recent Developments in the DNA Testing Market
5. Global DNA Testing Growth Analysis and Strategic Analysis Framework
6. DNA Testing Market Segmentation
7. DNA Testing Market Regional and Country Analysis
8. Asia-Pacific DNA Testing Market
9. China DNA Testing Market
10. India DNA Testing Market
11. Japan DNA Testing Market
12. Australia DNA Testing Market
13. Indonesia DNA Testing Market
14. South Korea DNA Testing Market
15. Western Europe DNA Testing Market
16. UK DNA Testing Market
17. Germany DNA Testing Market
18. France DNA Testing Market
19. Italy DNA Testing Market
20. Spain DNA Testing Market
21. Eastern Europe DNA Testing Market
22. Russia DNA Testing Market
23. North America DNA Testing Market
24. USA DNA Testing Market
25. Canada DNA Testing Market
26. South America DNA Testing Market
27. Brazil DNA Testing Market
28. Middle East DNA Testing Market
29. Africa DNA Testing Market
30. DNA Testing Market Competitive Landscape and Company Profiles
31. DNA Testing Market Other Major and Innovative Companies
35. DNA Testing Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
DNA Testing Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on dna testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for dna testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Equipment; Consumables; Software and Services2) By Technology: Polymerase Chain Reaction (PCR) Based; in-Situ Hybridization; Microarray; Next-Generation Sequencing (NGS) DNA Diagnosis
3) By Application: Newborn DNA Screening; Pre-Natal DNA Carrier Screening; Oncology Diagnostics and Histopathology; Pre-implantation Diagnosis; Infectious Disease Diagnostics; Pharmacogenomics Diagnostic Testing; Identify Diagnostics and Forensic; Other Applications
Subsegments:
1) By Equipment: DNA Analyzers; PCR (Polymerase Chain Reaction) Machines; Sequencers; Electrophoresis Systems; Other DNA Testing Instruments2) By Consumables: Reagents and Kits; PCR Consumables (Primers, Probes); DNA Extraction Kits; Sample Collection Devices; Others (DNA Markers, Electrophoresis Gels)
3) By Software: Data Analysis Software; Laboratory Information Management System (LIMS); Genetic Analysis Software; Bioinformatics Software; Other DNA Testing Software Solutions
4) By Services: Testing Services (Genetic Testing, Forensic Testing, Etc.); Data Interpretation Services; Consultation Services (Genetic Counseling); Laboratory Services (Sample Processing, DNA Sequencing Services); Other DNA Testing Services
Key Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this DNA Testing market report include:- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers GmbH
- Becton, Dickinson and Company
- GE HealthCare Technologies Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Quest Diagnostics Incorporated
- Eurofins Scientific SE
- Agilent Technologies
- Illumina Inc.
- PerkinElmer Inc.
- bioMérieux SA
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Natera Inc
- Myriad Genetics Inc.
- BGI Genomics Co. Ltd.
- Cepheid
- NeoGenomics Laboratories Inc
- Ancestry.com LLC
- 23andMe Holding Co
- Ambry Genetics Corporation
- MyHeritage Ltd
- Biocartis SA
- CENTOGENE N.V.
- Everlywell Inc
- Atlas Biomed Group Limited
- Veritas Genetics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 20.08 Billion |
| Forecasted Market Value ( USD | $ 31.38 Billion |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
